Stay updated on Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange Detected403 Forbidden page is shown in place of the study record, removing access to the study details and related sections. This indicates the page is now restricted to access.SummaryDifference17%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, indicating a minor maintenance update. No study details, eligibility criteria, or other user-facing content were modified.SummaryDifference0.1%

- Check52 days agoChange DetectedFooter now shows Revision: v3.6.5, replacing the previous v3.6.4; this indicates a small site update and does not change the study information displayed on the page.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This appears to be a minor maintenance update with no changes to study content or data visible on the page.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3; the page's content and structure related to the study details remain unchanged.SummaryDifference0.1%

- Check94 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor build/format update to the study details page without altering its substantive content.SummaryDifference0.1%

Stay in the know with updates to Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.